Latest Articles
The Fragmented Nightmare of Modern Drug Discovery Ends Here. We've Been Building EMET for a Decade. Here It Is.
company
BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board
company
BenchSci Extends ASCEND Agreement with Merck to Support Preclinical Disease Biology Research
press
BenchSci Ranked Among Fastest-Growing Companies in North America on the 2025 Deloitte Technology Fast 500™
press
BenchSci and Mila Partner to Advance AI for Biological Inference and Accelerate Drug Discovery
press
BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform
press
BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity
press
BenchSci Named To The Globe and Mail's Canada's Top Growing Companies 2025 List
press
BenchSci Expands Board of Directors with Appointment of Dr. Mikael Dolsten
press
BenchSci Bolsters Leadership Team with Deep AI and Pharma Expertise
press